Bayforest Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21K Buy
10
+9
+900% +$2.49K ﹤0.01% 884
2026
Q1
$295 Sell
1
-555
-100% -$165K ﹤0.01% 868
2025
Q4
$152K Sell
556
-967
-63% -$263K 0.11% 361
2025
Q3
$411K Buy
1,523
+1,109
+268% +$302K 0.2% 192
2025
Q2
$114K Buy
+414
New +$113K 0.05% 457

Other funds holding CME

Bayforest Capital's CME Position: Q2 2026 in Review

Bayforest Capital increased its CME Group (CME) stake by 900% in Q2 2026, buying an estimated $2.49K and bringing the position to 10 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Bayforest Capital first reported a position in CME in Q2 2025 and has held it in 5 quarters since. The position peaked at $411K in Q3 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bayforest Capital held 10 shares of CME Group worth $2.21K as of Q2 2026.
  • Bayforest Capital bought 9 CME Group shares in Q2 2026, an estimated $2.49K.
  • CME Group made up ﹤0.01% of Bayforest Capital's portfolio in Q2 2026, its #884 holding.
  • Bayforest Capital first reported a position in CME Group in Q2 2025 and has held it in 5 quarters since.
  • Bayforest Capital's CME Group position peaked at $411K in Q3 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.